Annexin Pharmaceuticals AB (publ) (ANNX) Stock Price & News

ANNX:STO

Annexin Pharmaceuticals AB (publ)

9,04 SEK

+1,12%

(+0,10) 1D

13-ноя., 17:29:37 GMT+1 · SEK

All symbols

	Symbol	Price	Change	% Change

Generating top insights for ANNX...

Open

8,62 SEK

High

9,04 SEK

Low

8,32 SEK

Mkt. cap

78,81 млн

Avg. vol.

7,59 миң

Volume

0,00

52-wk high

26,99 SEK

52-wk low

6,24 SEK

EPS

-5,81 SEK

Shares outstanding

8,72 млн

No. of employees

Open

8,62 SEK

High

9,04 SEK

Low

8,32 SEK

Mkt. cap

78,81 млн

Avg. vol.

7,59 миң

Volume

0,00

52-wk high

26,99 SEK

52-wk low

6,24 SEK

EPS

-5,81 SEK

Shares outstanding

8,72 млн

No. of employees

Related stocks

ACTI

Active Biotech AB publ

News stories

From web sources and news partners

TradingKey

7 саат мурун

S&P 500 Forecast: Index Poised to Retest Record High in November After 500-Point Pullback, Biggest Daily Gain in Nearly Seven Months

Foreign Policy Journal

7 саат мурун

Dow Jones Industrial Average (DJIA) Stays Green While Nasdaq Tumbles Nearly 1% In Sharp Rotation Trade

The Motley Fool

18 саат мурун

Prediction: This Small-Cap Value ETF Will Beat the S&P 500 Over the Next 10 Years

TradingView

15 саат мурун

EXCLUSIVE: S&P 500’s Sell-Off Tested Buffered ETFs: Expert Explains Why a 10% Buffer May Not Protect You as Expected

About Annexin Pharmaceuticals AB (publ)

CEO-

Employees4

Founded2014

Headquarters-

SectorHealth Care

IndustryPharmaceutical industry

Websiteannexinpharma.se

All values in SEK	2025-ж. дек.	2026-ж. мар.	2026-ж. июн.	2026-ж. сен.
Revenue	-	-	-	-
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	8,00 млн	7,92 млн	8,48 млн	6,89 млн
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	2,26 млн	2,90 млн	2,96 млн	2,61 млн
Operating expense	10,26 млн	10,82 млн	11,14 млн	9,50 млн
Total operating expenses	10,26 млн	10,82 млн	11,14 млн	9,50 млн
Operating income	-10,26 млн	-10,82 млн	-11,14 млн	-9,50 млн
Other non operating income	-	-	1,00 миң	-
EBT including unusual items	-10,52 млн	-10,52 млн	-11,56 млн	-9,49 млн
EBT excluding unusual items	-10,52 млн	-10,52 млн	-11,56 млн	-9,49 млн
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-288,00 миң	-
Net income	-10,52 млн	-10,52 млн	-11,56 млн	-9,49 млн
Net profit margin	-	-	-	-
Earnings per share	-	-	-	-
Interest and investment income	231,00 миң	34,00 миң	-	-
Interest expense	-	-	-	-
Net interest expenses	231,00 миң	34,00 миң	-	-
Depreciation and amortization charges	-	-	-	-
EBITDA	-10,21 млн	-10,77 млн	-11,10 млн	-9,45 млн
Gain or loss from assets sale	-	-	-	-

Finance

Ask anything